Most healthy adults with no heart symptoms do not need a routine EKG on any fixed schedule. Major medical organizations in the United States actively recommend against screening EKGs for people at low risk of cardiovascular disease, and no guideline sets a universal interval like “every year” or “every five years” for everyone. How often you should get one depends almost entirely on your personal risk profile, your symptoms, and whether you fall into a specific group where the test has proven value.
What the Guidelines Actually Say About Routine Screening
The U.S. Preventive Services Task Force has been clear on this for over a decade: it recommends against screening with either resting or exercise EKG in asymptomatic adults at low risk for coronary heart disease events.1PubMed. Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement That recommendation was reaffirmed in 2018, when the task force also noted insufficient evidence to judge the balance of benefits and harms for people at moderate to high risk.2JAMA. Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement The reasoning is straightforward: for a low-risk person, the test rarely changes what a doctor would do, and abnormal readings in healthy people tend to trigger further testing that doesn’t improve outcomes.
Other organizations align with this position. The American College of Physicians, the American Academy of Family Physicians, and the American College of Preventive Medicine all recommend against routine EKG screening in asymptomatic, low-risk adults.2JAMA. Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement The American College of Cardiology takes a slightly more permissive stance for people at intermediate or high risk of cardiovascular events, considering an exercise EKG potentially appropriate for those groups, but still calling it rarely appropriate for low-risk individuals.
A 2024 study in JAMA Internal Medicine reinforced this further, finding that routine EKG screening in low-risk populations lacks evidence that it improves decision-making or outcomes, and may even cause harm through unnecessary follow-up testing.3JAMA Internal Medicine. Routine Electrocardiogram Screening and Cardiovascular Disease Events in Adults The American College of Physicians has stated plainly that cardiac screening with EKG, stress echocardiography, or myocardial perfusion imaging has not been shown to improve patient outcomes in low-risk populations and can lead to cascades of additional procedures triggered by false positives.4PubMed. Cardiac screening with electrocardiography, stress echocardiography, or myocardial perfusion imaging: advice for high-value care from the American College of Physicians
When an EKG Is Worth Getting
The guidelines above apply to people who feel fine and have no known heart conditions. Once symptoms enter the picture, the calculus changes entirely. If you have chest pain, unexplained shortness of breath, palpitations, dizziness, or fainting spells, your doctor will almost certainly order an EKG as part of the initial workup. In those situations, the question of “how often” doesn’t really apply because the test is driven by the clinical moment, not a calendar.
Beyond acute symptoms, several chronic conditions make periodic EKGs genuinely useful. If you have high blood pressure, for example, your doctor may check for signs of left ventricular hypertrophy, a thickening of the heart’s main pumping chamber that signals the heart is working harder than it should. Tracking this over time matters: one study found that patients whose EKGs showed persistent or worsening left ventricular hypertrophy during blood pressure treatment had substantially higher risks of cardiovascular events and death.5PubMed Central. Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension For people on blood pressure medication, periodic EKGs can help confirm the treatment is actually protecting the heart, not just lowering the numbers on a blood pressure cuff.
Heart failure, a prior heart attack, diabetes, and known arrhythmias are other conditions where your cardiologist will likely schedule EKGs on a recurring basis. How frequently depends on the severity and stability of your condition. Someone with well-controlled atrial fibrillation might get an EKG once or twice a year to check their heart rhythm and rate. Someone recently hospitalized for heart failure might get one every few months initially, tapering as things stabilize. These intervals are clinical judgment calls, not one-size-fits-all recommendations.
Before Surgery
If you’re scheduled for a procedure, you might assume a pre-operative EKG is standard. It used to be. But current evidence and guidelines have pulled back from that blanket approach. For low-risk surgeries in asymptomatic patients, both the American College of Cardiology/American Heart Association and the European Society of Cardiology now say a routine pre-operative EKG is not recommended.6PubMed Central. Preoperative cardiac evaluation in elective non-cardiac surgery in India: Routine ECG, echocardiography, and angiography are not mandatory Unnecessary pre-surgical testing in these situations didn’t improve outcomes and sometimes caused delays.
For intermediate- or high-risk surgeries, especially in patients with known cardiovascular disease, a baseline EKG is considered reasonable. A large retrospective study of over 23,000 patients found that those with abnormal pre-operative EKGs had a higher rate of cardiovascular death compared to those with normal results, but for low-risk and low-to-intermediate-risk procedures, the absolute difference was small, around half a percentage point.7European Heart Journal. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery The bottom line: if you’re having minor outpatient surgery and you’re otherwise healthy, don’t be surprised if your surgeon skips the EKG. If you’re having a major operation or have a heart condition, expect one.
Screening Young Athletes
This is one of the most debated areas in sports medicine. The fear of sudden cardiac death in a young, apparently healthy athlete is terrifying, and it has driven conversations about whether every young person should get an EKG before playing competitive sports. Italy has required EKG screening for young competitive athletes since the 1980s, and data from that program showed a roughly 90% reduction in the annual rate of sudden cardiac death among screened athletes.8PubMed. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death That finding has been widely cited as evidence for universal screening.9PubMed Central. Cardiac screening to prevent sudden death in young athletes
A cost-effectiveness analysis concluded that screening young athletes with a 12-lead EKG plus a cardiovascular-focused history and physical examination may be cost-effective.10PubMed Central. Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes In asymptomatic children, the EKG performs well at detecting conditions like hypertrophic cardiomyopathy and long QT syndrome, though the positive predictive value varies with how common these conditions actually are in the population being screened.11PubMed Central. Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis
Despite this, the United States has not adopted mandatory EKG screening for young athletes. The reasons are practical: the sheer number of young athletes makes universal screening logistically challenging, the rate of false positives creates anxiety and unnecessary follow-up, and interpretation can be tricky because athletic hearts often look different on an EKG without anything actually being wrong. A recent review acknowledged that screening can detect otherwise silent cardiovascular disease, but highlighted the challenges of false positives, false negatives, and the ethical weight of disqualifying someone from sport based on a screening result.12PubMed Central. Cardiac screening in athletes: benefits and potential challenges If you or your child plays competitive sports, asking your pediatrician about an EKG during the pre-participation physical is reasonable, even if it isn’t required.
Older Adults and Atrial Fibrillation
As you age, the likelihood of developing atrial fibrillation rises sharply, and atrial fibrillation is a major driver of stroke risk. This has led to interest in whether routine EKG screening in older adults might catch the condition early enough to start blood thinners and prevent strokes. The evidence so far is mixed, and the answer seems to depend on just how old you are.
The VITAL-AF trial screened people aged 65 and older using a single-lead EKG during primary care visits and found no overall increase in new atrial fibrillation diagnoses compared to usual care. But among people aged 85 and older, the screening group did see more diagnoses than the control group.13PubMed Central. Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial A separate randomized trial using continuous ECG monitoring in older adults found screening detected atrial fibrillation in about 5% of those screened, compared to less than 1% in the control group, with most newly detected patients going on to start anticoagulation therapy.14JAMA Cardiology. Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial
The question that remains unanswered is whether detecting and treating these cases actually reduces strokes and death in the long run. Finding atrial fibrillation is only helpful if treating it early produces better outcomes than catching it when symptoms eventually appear. For now, routine screening with EKG in all older adults is not universally recommended, but it may make sense for people in their 80s and beyond, or for those with additional stroke risk factors. This is a conversation worth having with your doctor as you get older.
When Medications Require EKG Monitoring
Certain drugs can affect your heart’s electrical system, particularly by prolonging the QT interval, a measurement on the EKG that reflects how long your heart takes to recharge between beats. An abnormally long QT interval raises the risk of dangerous heart rhythms. Many cancer therapies are known to carry this risk, and guidelines call for a baseline EKG before starting any potentially QT-prolonging treatment, with follow-up EKGs during the first one to two weeks and after any dose increase.15PubMed Central. How to Diagnose and Manage QT Prolongation in Cancer Patients
Cancer therapy isn’t the only context. Some psychiatric medications, certain antibiotics, anti-nausea drugs, and heart rhythm medications themselves can prolong the QT interval. If you’re prescribed any of these, your doctor should be checking your EKG at baseline and periodically during treatment. How often depends on the drug, the dose, and your individual risk factors like kidney function and electrolyte levels. If your doctor doesn’t mention EKG monitoring when starting one of these medications, it’s worth asking about.
Family History of Sudden Death
A family history of unexplained sudden death, especially in someone under 40, changes the screening picture significantly. A study evaluating children who were relatives of people who died suddenly found that about 9% were diagnosed with a heritable cardiac disease, and another 12% had clinical findings of uncertain significance, many of which were detected by electrical testing.16PubMed Central. Cardiac Evaluation of Children With a Family History of Sudden Death Conditions like long QT syndrome, Brugada syndrome, and hypertrophic cardiomyopathy run in families, and an EKG is often the first step in identifying them.
If a close relative died suddenly and unexpectedly from a cardiac cause, or even from an unexplained cause, you and your family members should be screened. A single EKG might be sufficient to rule out some conditions, but others, particularly those that cause intermittent rhythm disturbances, might require extended monitoring or repeat testing over time. Genetic testing is increasingly part of this workup as well, but the EKG remains a frontline tool.
Wearable Devices and Their Limits
Smartwatches and consumer wearables that can record a single-lead EKG have complicated the “how often” question in a new way. You can technically get an EKG any time you want by pressing a button on your wrist. A systematic review and meta-analysis found that smartwatch EKGs detect atrial fibrillation with a sensitivity of about 86% and specificity of about 94% when read by the device’s algorithm, with even better performance when read by a clinician.17PubMed Central. Accuracy and interpretability of smartwatch electrocardiogram for early detection of atrial fibrillation: A systematic review and meta-analysis A smaller emergency department study confirmed that smartwatches showed high accuracy for detecting atrial fibrillation and supraventricular tachycardia against standard 12-lead EKGs.18Heliyon. Evaluation of smartwatch-based rhythm analysis in emergency department patients presenting with atrial fibrillation and supraventricular tachycardia
These devices can be genuinely useful for people who experience intermittent symptoms like palpitations, since the ability to capture an EKG in the moment beats waiting weeks for a doctor’s appointment. But there’s a real downside to constant monitoring in healthy people: you get more data than you know what to do with. A single-lead smartwatch trace is a fraction of what a standard 12-lead clinical EKG shows. It can’t detect many structural problems, and its algorithms aren’t designed for the full range of conditions a cardiologist looks for. If you’re using a wearable to monitor a known condition or capture infrequent symptoms, that’s a solid use case. If you’re checking it three times a day out of anxiety with no symptoms and no risk factors, you’re more likely to generate worry than useful information.
For people who need more than a snapshot, clinical options include Holter monitors worn for 24 to 48 hours and implantable loop recorders that can monitor continuously for months, allowing detection of arrhythmias that happen too rarely to catch on a single EKG.19PubMed Central. Holter Monitoring and Loop Recorders: From Research to Clinical Practice
The Problem With a “Baseline” EKG
You’ll sometimes hear advice to get a baseline EKG while healthy so that if something happens later, doctors can compare. It sounds logical, but the evidence behind it is thin. A study specifically examining the value of baseline EKGs for patients who later presented with acute cardiac symptoms found that in the vast majority of cases, clinical and EKG findings at the time of the event were diagnostic enough on their own. The baseline EKG could not have changed the decision to admit or discharge the patient. In less than 5% of cases might a prior EKG have been useful, and there was no case where it would have prevented an inappropriate discharge.20JAMA. The Baseline ECG in the Evaluation of Acute Cardiac Complaints
That said, this study is several decades old, and clinical practice has evolved. Some doctors still see value in having a comparison tracing, particularly for patients with conditions like bundle branch block that can mimic heart attack patterns. But using the baseline argument as a reason for annual EKGs in healthy people stretches the evidence beyond what it supports.
Disparities in Who Gets Tested
Access to cardiac testing isn’t evenly distributed. A study analyzing U.S. emergency department visits between 2009 and 2015 found that Black patients presenting with chest pain were less likely to have an EKG ordered compared to white patients. Patients with Medicaid, Medicare, or no insurance were also less likely to receive an EKG than those with private insurance.21The American Journal of Emergency Medicine. Racial and insurance disparities among patients presenting with chest pain in the US: 2009–2015 These gaps exist alongside well-documented broader disparities in cardiovascular care, including delayed presentation and reduced access to advanced cardiac procedures among Black and Hispanic populations.22Trends in Cardiovascular Medicine. Racial and ethnic disparities in percutaneous coronary intervention: contemporary evidence and pathways to equity
The irony is sharp: guidelines warn against over-testing in low-risk populations, but under-testing in higher-risk populations with actual symptoms is a parallel and arguably more dangerous problem. If you’re experiencing cardiac symptoms and feel your concerns aren’t being taken seriously, advocating for yourself or asking a family member to advocate for you is important.
How Artificial Intelligence May Change the Equation
One reason the EKG has been limited as a screening tool is that even experienced cardiologists can only extract so much from the squiggly lines on the printout. AI is changing that. Deep learning models trained on massive datasets of EKGs paired with imaging and clinical outcomes can now detect conditions that human experts cannot see on the tracing. A landmark study demonstrated that an AI model could screen for asymptomatic left ventricular dysfunction from an EKG alone, even when the abnormality was invisible to experienced readers.23PubMed Central. Artificial intelligence-enabled electrocardiography from scientific research to clinical application
More recently, a deep learning model called EchoNext, trained on over a million heart rhythm and imaging records, demonstrated high accuracy in detecting many forms of structural heart disease from standard EKGs, outperforming cardiologists in controlled evaluations and showing consistent results across different racial and ethnic groups. In a clinical trial, it successfully identified previously undiagnosed heart disease in patients who had never had cardiac imaging.24Nature. Detecting structural heart disease from electrocardiograms using AI AI-enhanced EKG models have also shown potential for detecting silent atrial fibrillation and hypertrophic cardiomyopathy from a standard tracing.25Nature Reviews Cardiology. Artificial intelligence-enhanced electrocardiography in cardiovascular disease management
This matters for the “how often” question because it could eventually shift the cost-benefit analysis. If a cheap, quick EKG processed by AI can reliably detect structural heart disease that would otherwise require an echocardiogram to find, the case for opportunistic screening during routine primary care visits gets a lot stronger. An EKG screening study in primary care in India, targeting high-risk adults, already demonstrated strong cost-effectiveness with the conventional test.26PubMed Central. Cost-Effectiveness of Portable Electrocardiogram for Screening Cardiovascular Diseases at a Primary Health Center in Ahmedabad District, India Pairing portable EKGs with AI interpretation in primary care settings could make screening both cheaper and more informative, particularly in communities where access to cardiologists and advanced imaging is limited. We aren’t there yet in terms of guidelines catching up, but the technology is moving fast.
Occupational Requirements
Certain jobs require periodic cardiac screening regardless of symptoms. Commercial airline pilots, military personnel, firefighters, and law enforcement officers may be required to undergo EKGs at regular intervals as part of occupational fitness assessments. A cardiovascular screening study of aircraft pilots found that most showed normal cardiac function, with fewer than 8% exhibiting positive findings on exercise EKG or imaging during functional testing.27Heart (BMJ Publishing Group). Cardiovascular screening and long-term outcomes in aircraft pilots For the UK’s SAFE study on atrial fibrillation screening in people 65 and older, opportunistic screening during routine visits was the most cost-effective approach, with a relatively low cost per additional case detected.28Health Technol Assess. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
If your job requires cardiac clearance, the frequency is typically set by your employer or regulatory body, and it isn’t optional. For everyone else, the schedule depends on your risk factors, your symptoms, and your doctor’s clinical judgment. The honest answer to “how often should you have an EKG” for most people is: when there’s a clinical reason, and not on a fixed calendar just because it feels responsible.